Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients

Background. Dyslipidemia is common and is often treated with 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors (statins). Little is known about the comparative effectiveness of statins among human immunodeficiency virus (HIV)–infected patients. This study compared the effectivenes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Singh, Sudershan, Willig, James H., Mugavero, Michael J., Crane, Paul K., Harrington, Robert D., Knopp, Robert H., Kosel, Bradley W., Saag, Michael S., Kitahata, Mari M., Crane, Heidi M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2011
Matèries:
HIV/AIDS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3106249/
https://ncbi.nlm.nih.gov/pubmed/21189273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciq111
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars